Connection

Swapan Ray to Brain Neoplasms

This is a "connection" page, showing publications Swapan Ray has written about Brain Neoplasms.
Connection Strength

6.438
  1. Regulation of autophagy as a therapeutic option in glioblastoma. Apoptosis. 2021 12; 26(11-12):574-599.
    View in: PubMed
    Score: 0.576
  2. Targeting autophagy for combating chemoresistance and radioresistance in glioblastoma. Apoptosis. 2018 12; 23(11-12):563-575.
    View in: PubMed
    Score: 0.471
  3. miR-30e Blocks Autophagy and Acts Synergistically with Proanthocyanidin for Inhibition of AVEN and BIRC6 to Increase Apoptosis in Glioblastoma Stem Cells and Glioblastoma SNB19 Cells. PLoS One. 2016; 11(7):e0158537.
    View in: PubMed
    Score: 0.399
  4. Anti-tumor activities of luteolin and silibinin in glioblastoma cells: overexpression of miR-7-1-3p augmented luteolin and silibinin to inhibit autophagy and induce apoptosis in glioblastoma in vivo. Apoptosis. 2016 Mar; 21(3):312-28.
    View in: PubMed
    Score: 0.390
  5. Synergistic anti-tumor actions of luteolin and silibinin prevented cell migration and invasion and induced apoptosis in glioblastoma SNB19 cells and glioblastoma stem cells. Brain Res. 2015 Dec 10; 1629:85-93.
    View in: PubMed
    Score: 0.380
  6. Direct transfection of miR-137 mimics is more effective than DNA demethylation of miR-137 promoter to augment anti-tumor mechanisms of delphinidin in human glioblastoma U87MG and LN18 cells. Gene. 2015 Nov 15; 573(1):141-52.
    View in: PubMed
    Score: 0.373
  7. Sequential hTERT knockdown and apigenin treatment inhibited invasion and proliferation and induced apoptosis in human malignant neuroblastoma SK-N-DZ and SK-N-BE2 cells. J Mol Neurosci. 2013 Sep; 51(1):187-98.
    View in: PubMed
    Score: 0.316
  8. Survivin knockdown and concurrent 4-HPR treatment controlled human glioblastoma in vitro and in vivo. Neuro Oncol. 2010 Nov; 12(11):1088-101.
    View in: PubMed
    Score: 0.265
  9. Flavonoids activated caspases for apoptosis in human glioblastoma T98G and U87MG cells but not in human normal astrocytes. Cancer. 2010 Jan 01; 116(1):164-76.
    View in: PubMed
    Score: 0.254
  10. Combination of hTERT knockdown and IFN-gamma treatment inhibited angiogenesis and tumor progression in glioblastoma. Clin Cancer Res. 2009 Dec 01; 15(23):7186-95.
    View in: PubMed
    Score: 0.252
  11. Modulatory effects of acetazolomide and dexamethasone on temozolomide-mediated apoptosis in human glioblastoma T98G and U87MG cells. Cancer Invest. 2008 May; 26(4):352-8.
    View in: PubMed
    Score: 0.226
  12. Retinoids induced astrocytic differentiation with down regulation of telomerase activity and enhanced sensitivity to taxol for apoptosis in human glioblastoma T98G and U87MG cells. J Neurooncol. 2008 Mar; 87(1):9-22.
    View in: PubMed
    Score: 0.219
  13. Intracranial stereotaxic cannulation for development of orthotopic glioblastoma allograft in Sprague-Dawley rats and histoimmunopathological characterization of the brain tumor. Neurochem Res. 2007 Dec; 32(12):2235-42.
    View in: PubMed
    Score: 0.215
  14. Differentiation decreased telomerase activity in rat glioblastoma C6 cells and increased sensitivity to IFN-gamma and taxol for apoptosis. Neurochem Res. 2007 Dec; 32(12):2167-83.
    View in: PubMed
    Score: 0.215
  15. Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma. Neurochem Res. 2007 Dec; 32(12):2203-9.
    View in: PubMed
    Score: 0.215
  16. Combination of all-trans retinoic acid and interferon-gamma suppressed PI3K/Akt survival pathway in glioblastoma T98G cells whereas NF-kappaB survival signaling in glioblastoma U87MG cells for induction of apoptosis. Neurochem Res. 2007 Dec; 32(12):2194-202.
    View in: PubMed
    Score: 0.214
  17. Molecular mechanism of inositol hexaphosphate-mediated apoptosis in human malignant glioblastoma T98G cells. Neurochem Res. 2007 Dec; 32(12):2094-102.
    View in: PubMed
    Score: 0.214
  18. Curcumin suppressed anti-apoptotic signals and activated cysteine proteases for apoptosis in human malignant glioblastoma U87MG cells. Neurochem Res. 2007 Dec; 32(12):2103-13.
    View in: PubMed
    Score: 0.213
  19. 5-Aminolevulinic acid-based photodynamic therapy suppressed survival factors and activated proteases for apoptosis in human glioblastoma U87MG cells. Neurosci Lett. 2007 Mar 30; 415(3):242-7.
    View in: PubMed
    Score: 0.208
  20. Induction of apoptosis and immune response by all-trans retinoic acid plus interferon-gamma in human malignant glioblastoma T98G and U87MG cells. Cancer Immunol Immunother. 2007 May; 56(5):615-25.
    View in: PubMed
    Score: 0.202
  21. Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities. Mol Cancer. 2004 Dec 08; 3(1):36.
    View in: PubMed
    Score: 0.179
  22. Molecular evidence of apoptotic death in malignant brain tumors including glioblastoma multiforme: upregulation of calpain and caspase-3. J Neurosci Res. 2002 Jul 15; 69(2):197-206.
    View in: PubMed
    Score: 0.151
  23. Multi-targeted DATS prevents tumor progression and promotes apoptosis in ectopic glioblastoma xenografts in SCID mice via HDAC inhibition. J Neurooncol. 2013 Aug; 114(1):43-50.
    View in: PubMed
    Score: 0.081
  24. Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastoma. Metab Brain Dis. 2013 Sep; 28(3):355-66.
    View in: PubMed
    Score: 0.080
  25. Drug resistance in glioblastoma: a mini review. Neurochem Res. 2012 Jun; 37(6):1192-200.
    View in: PubMed
    Score: 0.073
  26. N-(4-Hydroxyphenyl) retinamide induced both differentiation and apoptosis in human glioblastoma T98G and U87MG cells. Brain Res. 2008 Aug 28; 1227:207-15.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.